**Core Concept**
Protein binding refers to the attachment of a drug to plasma proteins, primarily albumin and alpha-1-acid glycoprotein. This binding affects the drug's distribution, metabolism, and elimination. In patients with hypoalbuminemia, the reduced availability of albumin can alter the protein binding of certain drugs.

**Why the Correct Answer is Right**
Unbound (free) drug is pharmacologically active, while bound drug is inactive. In hypoalbuminemia, the proportion of unbound drug increases, potentially leading to toxicity. However, some drugs maintain their protein binding affinity even in low albumin conditions. One such example is **digoxin**, a cardiac glycoside used to treat heart failure. Digoxin's binding to albumin is not significantly affected by hypoalbuminemia.

**Why Each Wrong Option is Incorrect**
**Option A:** **Warfarin** is an anticoagulant with reduced protein binding affinity in hypoalbuminemia, increasing its risk of toxicity.
**Option B:** **Phenytoin**, an antiepileptic drug, exhibits non-linear pharmacokinetics and reduced protein binding in hypoalbuminemia, leading to increased free fraction and toxicity.
**Option C:** **Valproic acid**, another antiepileptic, has reduced protein binding affinity in hypoalbuminemia, increasing its risk of toxicity and adverse effects.

**Clinical Pearl / High-Yield Fact**
In patients with hypoalbuminemia, monitor the free fractions of drugs with altered protein binding, such as warfarin, phenytoin, and valproic acid, to prevent toxicity.

**Correct Answer:** C.